Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study.

Angelo LabateFrancesco FortunatoAlessia GiugnoIolanda MartinoMaria Eugenia Caligiuri Antonio Gambardella

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)

PER was significantly successful and tolerated in MTLE patients when used as first add-on option rather than as late add-on.

Keyphrases

temporal lobe epilepsy
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
patient reported outcomes
decision making